当前位置:首页 - 行情中心 - 步长制药(603858) - 财务分析 - 现金流量表

步长制药

(603858)

  

流通市值:184.93亿  总市值:184.93亿
流通股本:11.06亿   总股本:11.06亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金10,091,889,612.096,918,544,864.453,313,591,507.6215,488,715,762.62
收到的税费返还10,208,921.691,092,555.65129,604.27202,416,612.65
收到其他与经营活动有关的现金198,185,806.69189,791,604.1497,637,160.9581,452,080.2
经营活动现金流入的平衡项目0000
经营活动现金流入小计10,300,284,340.477,109,429,024.243,411,358,272.8415,772,584,455.47
购买商品、接受劳务支付的现金3,028,269,673.611,441,105,549.67732,541,703.012,677,329,074.83
支付给职工以及为职工支付的现金821,439,234.26530,008,137.7271,680,949.11989,302,108.15
支付的各项税费1,509,380,523.851,144,039,967.48598,703,625.552,117,258,644.47
支付其他与经营活动有关的现金5,352,995,948.53,726,412,139.751,895,446,599.887,233,066,935.08
经营活动现金流出的平衡项目0000
经营活动现金流出小计10,712,085,380.226,841,565,794.63,498,372,877.5513,016,956,762.53
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-411,801,039.75267,863,229.64-87,014,604.712,755,627,692.94
二、投资活动产生的现金流量:
收回投资收到的现金380,000,000---
取得投资收益收到的现金12,713,126.699,324,015.4711,846,714.4110,860,096.7
处置固定资产、无形资产和其他长期资产收回的现金净额1,800,312.61229,554.6124,590484,241
收到的其他与投资活动有关的现金18,946,633.17312,937,222.847,407,166.0119,966,842.42
投资活动现金流入的平衡项目0000
投资活动现金流入小计413,460,072.47322,490,792.9219,278,470.4231,311,180.12
购建固定资产、无形资产和其他长期资产支付的现金386,058,268.39249,275,717.1587,679,475.27543,165,553.42
投资支付的现金67,500,00030,000,000250,000,000478,964,415
支付其他与投资活动有关的现金200,149.43200,149.43-19,360,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计453,758,417.82279,475,866.58337,679,475.271,041,489,968.42
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-40,298,345.3543,014,926.34-318,401,004.85-1,010,178,788.3
三、筹资活动产生的现金流量:
吸收投资收到的现金1,520,000200,000200,0003,060,000
其中:子公司吸收少数股东投资收到的现金1,520,000200,000200,0003,060,000
取得借款收到的现金1,343,370,0001,021,800,000475,000,0002,114,950,517.89
收到其他与筹资活动有关的现金1,856,403.0916,969,888.2666,162,487.2198,868,525.57
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,346,746,403.091,038,969,888.26541,362,487.22,316,879,043.46
偿还债务支付的现金1,265,671,264.46827,645,864.46600,391,932.232,705,025,005.7
分配股利、利润或偿付利息支付的现金1,181,001,038.1456,539,864.6830,499,904.71561,174,485.55
其中:子公司支付给少数股东的股利、利润17,480,584.93--13,836,850.32
支付其他与筹资活动有关的现金95,493,656.86110,609,721.3444,695,960.638,246,879.28
筹资活动现金流出平衡项目0000
筹资活动现金流出小计2,542,165,959.46994,795,450.48675,587,797.543,304,446,370.53
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,195,419,556.3744,174,437.78-134,225,310.34-987,567,327.07
四、汇率变动对现金及现金等价物的影响18,289.2720,599.11-12,851.44161,063.57
现金及现金等价物净增加额平衡项目0-0.0100
五、现金及现金等价物净增加额-1,647,500,652.2355,073,192.86-539,653,771.34758,042,641.14
加:期初现金及现金等价物余额2,121,316,547.862,121,316,547.862,121,316,547.861,363,273,906.72
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额473,815,895.662,476,389,740.721,581,662,776.522,121,316,547.86
补充资料:
净利润-683,581,016.15--1,590,982,971.16
资产减值准备-9,457,187.04-3,035,203,684.47
固定资产和投资性房地产折旧-189,221,417.01-292,754,132.17
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-189,221,417.01-292,754,132.17
无形资产摊销-96,197,382.69-187,203,511.61
长期待摊费用摊销-4,160,695.97-8,072,317.9
处置固定资产、无形资产和其他长期资产的损失--16,168.81--773,103.41
固定资产报废损失-91,992.47-1,432,297.15
公允价值变动损失--1,178,058.08--
财务费用-35,099,430.06-115,226,267.23
投资损失--19,373,338.4--2,735,495.74
递延所得税--64,068,645.43--19,407,477.76
其中:递延所得税资产减少--74,561,748.63--699,380.67
递延所得税负债增加-10,493,103.2--18,708,097.09
存货的减少--173,578,009.06-39,521,819.78
经营性应收项目的减少--183,628,017.25-483,364,156.6
经营性应付项目的增加--308,655,922.88-172,012,619.3
现金的期末余额-2,476,389,740.72-2,121,316,547.86
减:现金的期初余额-2,121,316,547.86-1,191,550,906.72
减:现金等价物的期初余额---171,723,000
公告日期2023-10-282023-08-262023-04-282023-04-28
审计意见(境内)标准无保留意见
TOP↑